Kratom Research Institute

Safety · 2026-08-01

Biochemist: Synthetic 7-OH Products 7 to 13 Times More Potent Than Morphine, Labels Untrustworthy

Source: 12News KPNX (Phoenix)

Why it matters

A biochemist with experience studying Schedule I substances explains why product labels for 7-OH products are unreliable and why even the threshold set by the DEA may be hard to enforce without field-testing technology.

The big picture

The DEA's Schedule I action on concentrated 7-OH is aimed at products sold in gas stations and smoke shops — often marketed for pain or anxiety relief — that can contain highly concentrated synthetic versions of a compound far more potent than morphine. The regulatory gap is stark: products can claim any concentration on their label with no oversight body verifying those claims. Even when the scheduling order takes effect, enforcement will rely on self-reported product labels, which research has shown are frequently inaccurate.

Key findings

What they say

Biochemical engineer Moshe Williams warned: "You can stop breathing from this. People have died from using this drug just because of how potent it is — 7 to 13 times more potent than morphine. Who knows who's making it? Are they a pharmacist? I doubt it."

Bottom line

The DEA's 7-OH scheduling faces a real enforcement gap: without portable field-testing, regulators must rely on product labels that experts say are routinely inaccurate for substances that can be 13 times more potent than morphine.